The goal of this study is to investigate the utility of labetalol for cocaine dependence in humans. A total of 12 subjects (6 men and 6 women) will be enrolled in this double-blind, placebo controlled inpatient study. Subjects will be assigned to either low (0.25 mg/kg) or high dose of labetalol (0.5 mg/kg), or saline pretreatment group for the first experimental session and then will be crossed over to the alternative pretreatments for the second and third experimental sessions (crossover design). A single dose of cocaine (32 mg/70 kg) will be administered 15 min after labetalol or saline pretreatment. We propose that several physiological, behavioral and subjective effects of cocaine will be significantly blocked by labetalol pretreatment.
Showing the most recent 10 out of 724 publications